Papers matching “lymph node status prediction” 7
Not finding it? Sign in to also search OpenAlex live.
-
Use of Merlin Assay to identify patients with a low-risk for SN metastasis in a prospective multicenter Dutch study of a primary melanoma gene-signature (CP-GEP model) to predict sentinel node status during COVID-19.2022 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Evalyn E.A.P. Mulder, Antoine Veringa, Antien L. Mooyaart, Jvalini T. Dwarkasing, Dennie Tempel, Jos A. van der Hage, +5 more
3citations -
Prediction of axillary response in 5,262 patients with node-positive breast cancer treated with neoadjuvant chemotherapy: Results from the prospective multicenter AXSANA/EUBREAST-03/AGO-B-053 study.2026 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Thorsten Kühn, Steffi Hartmann, Jana de Boniface, Nina Caroline Ditsch, Oreste Gentilini, +15 more
0citations -
The prognostic performance of PREDICT+ in patients (pts) with HER2-positive (HER2+) early-stage breast cancer (EBC).2021 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Elisa Agostinetto, Lieveke Ameye, Samuel Martel, Philippe Georges Aftimos, Noam Falbel Ponde, Christian Maurer, +14 more
1citations -
Predictive performance of breast cancer index (BCI) and clinical treatment score post-5 years (CTS5) in the IDEAL study.2022 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Gerrit‐Jan Liefers, Iris Noordhoek, Hein Putter, Jenna Wong, Natalia Siuliukina, Yi Zhang, +5 more
4citations -
Assessment of risk of overall and late distant recurrence by Breast Cancer Index in postmenopausal women with early-stage, HR+ breast cancer in the TEAM trial.2023 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
John M.S. Bartlett, Keying Xu, Jenna Wong, Gregory R. Pond, Yi Zhang, Melanie Spears, +12 more
1citations -
Breast cancer index (BCI) predicts benefit of two-and-a-half versus five years of extended endocrine therapy in HR+ breast cancer patients treated in the ideal trial.2020 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Gerrit‐Jan Liefers, Iris Noordhoek, Kai Treuner, Hein Putter, Yi Zhang, Elma Meershoek‐Klein Kranenbarg, +3 more
4citations -
Abstract RF2-01: Prognostic Markers in Residual Tumors after neoadjuvant chemotherapy (NACT) for Early Triple-negative Breast Cancer (TNBC) - a Pooled Analysis from nine Neoadjuvant GBG/AGO-B Trials2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Johannes Holtschmidt, A. Schneeweiss, Nadine Frickel, Natalie Filmann, Michael Untch, A. D. Hartkopf, +20 more
3citations
7 results